Skip to main content
Caplight Logo









Ohalo Genetics

Ohalo Genetics

Private
Aptos, CaliforniaHealthcare & Life Scienceshttps://www.ohalo.com/

Last Round

Series B

Feb 24, 2025

Est. Valuation

$240M

Total Funding Raised

$130M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Ohalo Genetics is an agricultural biotechnology company that develops plant breeding technologies and crop varieties to improve yield, sustainability, and efficiency in global agriculture.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

Boosted Breedinggene editingplant breedingagtechbreeding systemsagricultural biotechnologycrop improvementplant geneticstrue seedtrait developmentcrop yieldcrop resiliencyseed companyseed technologygermplasm

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ohalo Genetics Comparables

Compare Ohalo Genetics with similar companies based on industry and business-model similarity.

Ohalo Genetics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pairwise
79%
Phytoform Labs
73%
Cibus, Inc.
73%

Ohalo Genetics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 24, 2025
Series AJan 25, 2024
VC RoundSep 23, 2021

Key People

Founding team and executive leadership

Judson Ward

Founder And Chief Technology Officer

Founding Team

David Friedberg

Chief Executive Officer

Executive Team

Ohalo Genetics Investors

Notable investors and investment history

Ohalo Genetics investors
InvestorRounds
Valor Capital GroupSeries A
S32Series A
The Production BoardSeries B, VC Round, Seed, Series A
Craft VenturesSeries A, Series B
S2G InvestmentsSeries B
HedosophiaSeries A
Valor Equity PartnersSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 39% MoM.

  • Jul 24, 2026

    Grew 16% QoQ, from 105 to 122 employees.

Ohalo Genetics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ohalo Genetics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ohalo Genetics's valuation, stock price, and market status.

Firmographic Details

HeadquartersAptos, California
Employee Range122
Year Founded2019
Last FundingFeb 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?